Díaz-Carrillo MA, Rosales-Gutiérrez AO, Neri-Maldonado R, Espinoza de los Monteros-Estrada I

Language: Spanish
References: 9
Page: 414-422
PDF size: 256.06 Kb.

ABSTRACT

The ongoing research and development of new anticoagulant/antiplatelet drugs deserves special attention in the evaluation and management of patients presenting for surgery. As part of the development of the ideal anticoagulant, the newer drugs aim to provide safe, effective, predictable anticoagulant activity and no need for monitoring. Anesthesiologists must be familiar with the newly developed anticoagulants because their use in the perioperative setting is likely increase as do the risks and benefits of discontinuation or reversal of the drugs before surgery.

REFERENCES

1. Atman R. Recomendaciones para la introducción de la terapéutica anticoagulante en el perioperatorio. Rev Fed Arg Cardiol. 2012;31:165-170.

2. Douketis J, Bakhsh E. Perioperative management of antithrombotic therapy. Pol Arch Med Wewn. 2008;118:201-208.

3. Gayle J, Kaye AD, Kaye AM, Shah R. Anticoagulants: newer ones, mechanisms, and perioperative updates. Anesthesiology Clin. 2010;28:667-679.

4. Oprea A, Popescu W. Perioperative management of antiplatelet therapy. British Journal of Anaesthesia. 2013;111(S1):i3-i17.

5. Spyropoulos AC, Bauersachs RM, Omran H, Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Curr Med Res Opin. 2006;22:1109-1122.

6. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res. 2002;108:3-13.

7. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;336:1506-1511.

8. Lai A, Davidson N, Galloway SW, Thachil J. Perioperative management of patients on new oral anticoagulants. Br J Surg. 2014;101:742-749.

9. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385-1413.